

Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma
David Fiorella, M.D., Ph.D. et al. 2024년 11월 20일 N Engl J Med 2025;392:855-864 DOI: 10.1056/NEJMoa2409845 Abstract Background Patients receiving standard treatment for chronic subdural hematoma have a high risk of treatment failure. The effect of adjunctive middle meningeal artery embolization on the risk of treatment failure in this population remains unknown. Methods We randomly assigned patients with symptomatic chronic subdural hematoma to undergo middle meningeal art
이정희
3일 전3분 분량


Peritumoral Edema in Gliomas: A Review of Mechanisms and Management
Kazufumi Ohmura 1,2 , Hiroyuki Tomita 1,3,* and Akira Hara 1 Biomedicines 2023, 11(10), 2731; https://doi.org/10.3390/biomedicines11102731 Submission received: 31 July 2023 / Revised: 29 September 2023 / Accepted: 6 October 2023 / Published: 9 October 2023 (This article belongs to the Special Issue Gliomas: Signaling Pathways, Molecular Mechanisms and Therapeutic Approaches) Abstract: Treating malignant glioma is challenging owing to its highly invasive potential in he
소영 정
5월 19일2분 분량


Management of Chronic Subdural Hematoma With Adjunctive Embolization of Middle Meningeal Artery The EMMA-Can Randomized Clinical Trial
Jai Jai Shiva Shankar, MD, DM, MSc1,2,3; Susan Alcock, MN1; Nima Kashani, MD1et al 2026년04월30일 JAMA Neurol. Published online: April 30, 2026. DOI:10.1001/jamaneurol.2026.4910 Importance Chronic subdural hematomas commonly recur after surgical drainage. The effect of adjunctive embolization of the middle meningeal artery (EMMA) on recurrence risk remains unclear. Objective To evaluate whether EMMA as an adjunct to surgical drainage reduces chronic subdural hematoma recurrenc
이정희
5월 8일3분 분량


Acute Brain Injury in New-Onset Refractory Status Epilepticus and Etiology-Defined Status Epilepticus
Stefano Meletti, MD, PhD1,2; Aurelie Hanin, PhD3,4; Giada Giovannini, MD, PhD1 et al 2026년04월27일 JAMA Neurol. Published online: April 27, 2026. DOI:10.1001/jamaneurol.2026.0865 Abstract Importance Seizure-induced brain injury is central to the treatment urgency of new-onset refractory status epilepticus (NORSE). Identifying biomarkers that reflect ongoing neuronal damage could inform therapeutic timing and improve outcomes. Objective To quantify acute brain injury in pati
이정희
4월 28일4분 분량


Tumor microenvironment in glioblastoma: Current and emerging concepts
Pratibha Sharma , Ashley Aaroe, Jiyong Liang, and Vinay K. Puduvalli Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA (P.S., A.A., J.L., V.K.P.) Corresponding Author: Vinay K. Puduvalli, MD, 1515 Holcombe Blvd, Unit 431, Houston, TX 77030, USA (vpuduval@mdanderson. org). Neuro-Oncology Advances 5(1), 1–16, 2023 | https://doi.org/10.1093/noajnl/vdad009 | Advance Access date 23 February 2023 Glioblastoma (GBM) tumor microenvir
소영 정
4월 27일2분 분량


Long-Term Mortality, Cognition, and Quality of Life After Chronic Subdural Hematoma Surgery
Thomas Petutschnigg, MD1 ; Samuel Aschwanden1 ; Claire Descombes, MSc1 et al 2026년 04월13일 JAMA Neurol . Published online: April 13, 2026. Doi: 10.1001/jamaneurol.2026.0656 Abstract Importance Chronic subdural hematoma (cSDH) is among the most common neurosurgical disorders in older adults. Although short-term outcomes after surgery are favorable, long-term survival and health-related quality of life (HRQoL) remain poorly characterized. Objectives To evaluate long-t
이정희
4월 20일4분 분량


Monro-Kellie 4.0: moving from intracranial pressure to intracranial dynamics
Sérgio Brasil1*, Gustavo C. Patriota2 , Daniel Agustín Godoy3 , Jorge L. Paranhos4 , Andrés Mariano Rubiano5 and Wellingson S. Paiva Crit Care. 2025 Jun 5;29:229. doi: 10.1186/s13054-025-05476-7 Abstract The Monro-Kellie doctrine, introduced in the late 18th century, was a groundbreaking concept aimed at explaining the interactions between intracranial volume components. It has since become a cornerstone of brain physiology, now recognized as intracranial dynamics. Initial
소영 정
4월 7일2분 분량


Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
Prescott, Hallie C. MD, MSc 1,2 ; Antonelli, Massimo MD 3,4 ; Alhazzani, Waleed MD, MSc, FRCPC 5,6,7 ; Møller, Morten Hylander MD, PhD 8,9 ; Alshamsi, Fayez MBBS 10 ; Azevedo, Luciano C. P. MD, PhD 11 ; Belley-Cote, Emilie MD, PhD 12,13,14 ; De Waele, Jan MD, PhD 15,16 ; Derde, Lennie MD, PhD 17,18 ; Dionne, Joanna C. MD, MSc, PhD, FRCPC 19,20 ; Evans, Laura MD 21 ; Gershengorn, Hayley B. MD 22,23 ; Hodgson, Carol L. PhD, PT, MPhils, PGDip(Crit Care) 24,25 ; Honarmand, Kimia
소영 정
3월 24일3분 분량


Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy
Emanuele Cerulli Irelli, MD, PhD1 ; Roberta Roberti, MD2 ; Maria Sole Borioni, MD1 et al 2026년 02월09일 JAMA Neurol . Published online: February 9, 2026 DOI:10.1001/jamaneurol.2025.5625 Abstract Importance Treatment decisions in drug-resistant focal epilepsy remain largely empirical, as direct comparative evidence among newer antiseizure medications (ASMs) is limited. Real-world data can complement randomized clinical trials by providing insights into long-term effectiv
이정희
3월 23일4분 분량


High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity
Sohyon Lee , Tobias Weiss , Marcel Bühler , Julien Mena , Zuzanna Lottenbach , Rebekka Wegmann , Miaomiao Sun , Michel Bihl , Bartłomiej Augustynek , Sven P. Baumann , Sandra Goetze , Audrey van Drogen , Patrick G. A. Pedrioli , David Penton , Yasmin Festl , Alicia Buck , Daniel Kirschenbaum , Anna M. Zeitlberger , Marian C. Neidert , Flavio Vasella , Elisabeth J. Rushing , Bernd Wollscheid , Matthias A. Hediger , Michael Weller & Berend Snijder ...
소영 정
3월 17일3분 분량


A new characterisation of acute traumatic brain injury: the NIH-NINDS TBI Classification and Nomenclature Initiative
Prof Geoffrey T Manley MD a , Prof Kristen Dams-O’Connor PhD b * , Michael L Alosco PhD c , Hibah O Awwad PhD d, Prof Jeffery J Bazarian MD e , Prof Peter Bragge BPhysio f , Prof John D Corrigan PhD g , Adele Doperalski PhD d, Prof Adam R Ferguson PhD a h , Prof Christine L Mac Donald PhD i , Prof David K Menon MD j , Prof Molly M McNett PhD k , Prof Joukje van der Naalt MD l , Prof Lindsay D Nelson PhD m , Dana Pisică MD n, Prof Noah D Silverberg PhD o...
이정희
3월 9일2분 분량


One-Year Outcomes After Traumatic Brain Injury and Early Extracranial Surgery in the TRACK-TBI Study
Christopher J. Roberts, MD, PhD1,2 ; Amelia W. Maiga, MD, MPH3,4,5 ; Jason Barber, MS6 ; et al 2025년10월 10일 JAMA Netw Open Published Online: October 10, 2025 DOI: 10.1001/jamanetworkopen.2025.372271 Abstract Importance Exposure to extracranial (EC) surgery early after traumatic brain injury (TBI) is associated with cognitive risks. Objective To examine whether exposure to EC surgery during a TBI index admission is associated with worse outcomes at 1 year compared with n
이정희
3월 4일4분 분량
The Next Era of Idiopathic Normal Pressure Hydrocephalus
Michael A. Williams, MD1 ; Mark G. Luciano, MD, PhD2 ; Jan Malm, MD, PhD3 et al 2026년02월06일 JAMA Neurol . Published online: February 2, 2026. Doi: 10.1001/jamaneurol.2025.5412 1965년 정상압 수두증(NPH)이 치료 가능한 치매의 한 형태 로 처음 기술된 이후, NPH에 대한 열광과 기대의 시대가 시작되었다. 당시에는 치매에 대한 치료가 거의 없었거나 상상조차 어려웠다. 곧 많은 치매 환자들이 방사성 동위원소 cisternography나 pneumo-encephalography를 기반으로 NPH로 진단받고 션트 수술을 받게 되었다. 초기에는 긍정적인 보고들이 쏟아졌지만, 이후 연구 결과에서는 점차 좋지 않은 결과들이 나타나기 시작했다. 1992년에 발표된 정상압 수두증에서 션트 수술의 이익이 위험
이정희
2월 20일3분 분량


Glioblastoma at the crossroads: current understanding and future therapeutic horizons
Shilpi Singh , Devanjan Dey , Debashis Barik , Iteeshree Mohapatra , Stefan Kim , Mayur Sharma , Sujata Prasad , Peize Wang , Amar Singh and Gatikrushna Singh Glioblastoma (GBM) remains the most aggressive and lethal brain tumor in adults and poses significant challenges to patient survival. This review provides a comprehensive exploration of the molecular and genetic landscape of GBM, focusing on key oncogenic drivers, such as epidermal growth factor receptor (EGFR), platelet
소영 정
2월 19일3분 분량


Emerging Therapies for Glioblastoma
AlissaA.Thomas,MD;CameronW.Brennan,MD;LisaM.DeAngelis,MD;AntonioM.Omuro,MD IMPORTANCE Glioblastoma is the most common primary malignant brain tumor, but despite multimodal treatment with surgery, radiotherapy, and temozolomide chemotherapy, the prognosis is poor, with a median survival of 16 to 19 months and poor quality of life throughout the disease course. New treatments are needed. EVIDENCE REVIEW Articles were identified through a search of PubMed references from March
소영 정
1월 26일2분 분량


Glioblastoma remodelling of human neural circuits decreases survival
Saritha Krishna , Abrar Choudhury , Michael B. Keough , Kyounghee Seo , Lijun Ni , Sofia Kakaizada , Anthony Lee , Alexander Aabedi , Galina Popova , Benjamin Lipkin , Caroline Cao , Cesar Nava Gonzales , Rasika Sudharshan , Andrew Egladyous , Nyle Almeida , Yalan Zhang , Annette M. Molinaro , Humsa S. Venkatesh , Andy G. S. Daniel , Kiarash Shamardani , Jeanette Hyer , Edward F. Chang , Anne Findlay , Joanna J. Phillips , Shawn L. Hervey-Jumper Natu
소영 정
1월 5일2분 분량


Risk of Future Hemorrhage From Unruptured Brain Arteriovenous Malformations The Multicenter Arteriovenous Malformation Research Study (MARS)
Helen Kim, PhD1,2 ; Jeffrey Nelson, MS1 ; Charles E. McCulloch, PhD2 et al 2025년 10월6일 JAMA Neurol . Published online: October 6, 2025. Doi: 10.1001/jamaneurol.2025.3581 Abstract Importance Annual rates of first intracranial hemorrhage (ICH) from unruptured brain arteriovenous malformations (AVMs) are often quoted as 2% to 4% in clinical practice. Precise estimates and risk factors are unavailable to inform treatment decisions. Objectives To provide estimates of ra
이정희
2025년 12월 23일4분 분량


The intensive care medicine research agenda for the management of ICU acquired weakness: a multinational, interprofessional perspective
Intensive Care Med, Volume 51, pages 2199-2212, (2025) Conference Repors and Expert Panel, Published: 03 November 2025 Doi: 10.1007/s00134-025-08186-4 Abstract Intensive care unit acquired weakness (ICUAW) is common in critically ill patients, contributing to substantial morbidity. Major trials and novel mechanistic findings published over the past years have advanced knowledge for the prevention and treatment of ICUAW. To streamline future research priorities, a multinat
이정희
2025년 12월 16일3분 분량


European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2025: post-resuscitation care
Intensive Care Med, Volume 51, pages 2213-2288, (2025) Conference Repors and Expert Panel, Published: 22 October 2025 Doi: 10.1007/s00134-025-08117-3 Abstract The European Resuscitation Council (ERC) and the European Society of Intensive Care Medicine (ESICM) have collaborated to produce these post-resuscitation care guidelines for adults, which are based on the International Consensus on Cardiopulmonary Resuscitation Science with Treatment Recommendations (CoSTR) pubis
이정희
2025년 12월 16일3분 분량


Glioblastoma and Other Primary Brain Malignancies in Adults A Review
Lauren R. Schaff, MD 1,2 ; Ingo K. Mellinghoff, MD 1,2,3,4 JAMA Published Online: February 21, 2023 2023;329;(7):574-587. doi:10.1001/jama.2023.0023 Abstract Importance Malignant primary brain tumors cause more than 15 000 deaths per year in the United States. The annual incidence of primary malignant brain tumors is approximately 7 per 100 000 individuals and increases with age. Five-year survival is approximately 36%. Observations Approximately 49% of malignant brain
소영 정
2025년 12월 15일3분 분량




